These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22020296)

  • 21. [The construction and expression of 6B11scFv anti-idiotypic antibody and human granulocyte-macrophage-colony stimulating factor in Escherichia coli].
    Yang F; Qian H; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):417-9. PubMed ID: 11360654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients.
    Battaglia A; Fossati M; Buzzonetti A; Scambia G; Fattorossi A
    Immunol Lett; 2017 Nov; 191():35-39. PubMed ID: 28919454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses.
    Forconi F; King CA; Sahota SS; Kennaway CK; Russell NH; Stevenson FK
    Immunology; 2002 Sep; 107(1):39-45. PubMed ID: 12225361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiidiotype induction therapy: evidence for the induction of immune response through the idiotype network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13.
    Madiyalakan R; Sykes TR; Dharampaul S; Sykes CJ; Baum RP; Hör G; Noujaim AA
    Hybridoma; 1995 Apr; 14(2):199-203. PubMed ID: 7590780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer.
    Nicholson S; Bomphray CC; Thomas H; McIndoe A; Barton D; Gore M; George AJ
    Cancer Immunol Immunother; 2004 Sep; 53(9):809-16. PubMed ID: 15127236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001.
    Wagner U; Köhler S; Reinartz S; Giffels P; Huober J; Renke K; Schlebusch H; Biersack HJ; Möbus V; Kreienberg R; Bauknecht T; Krebs D; Wallwiener D
    Clin Cancer Res; 2001 May; 7(5):1154-62. PubMed ID: 11350879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
    Sharma SK; Suresh MR; Wuest FR
    Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
    Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo.
    Noujaim AA; Schultes BC; Baum RP; Madiyalakan R
    Cancer Biother Radiopharm; 2001 Jun; 16(3):187-203. PubMed ID: 11471484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR.
    Pfisterer J; du Bois A; Sehouli J; Loibl S; Reinartz S; Reuss A; Canzler U; Belau A; Jackisch C; Kimmig R; Wollschlaeger K; Heilmann V; Hilpert F
    Ann Oncol; 2006 Oct; 17(10):1568-77. PubMed ID: 17005631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
    Spellerberg MB; Zhu D; Thompsett A; King CA; Hamblin TJ; Stevenson FK
    J Immunol; 1997 Aug; 159(4):1885-92. PubMed ID: 9257853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
    Reinsberg J; Krebs D
    Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy.
    Cheung NK; Guo HF; Modak S; Cheung IY
    Hybrid Hybridomics; 2003 Aug; 22(4):209-18. PubMed ID: 14511566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a delivery system for the continuous endogenous release of an anti-idiotypic antibody against ovarian carcinoma.
    Hann E; Reinartz S; Clare SE; Passow S; Kissel T; Wagner U
    Hybridoma (Larchmt); 2005 Jun; 24(3):133-40. PubMed ID: 15943560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients.
    Gordon AN; Schultes BC; Gallion H; Edwards R; Whiteside TL; Cermak JM; Nicodemus CF
    Gynecol Oncol; 2004 Aug; 94(2):340-51. PubMed ID: 15297171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of anti-idiotype scFv for pharmacokinetic measurement in lymphoma patients treated with chimera anti-CD22 antibody SM03.
    Zhao Q; Wong PF; Lee SS; Leung SO; Cheung WT; Wang JZ
    PLoS One; 2014; 9(5):e96697. PubMed ID: 24816427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The study of immunotherapy of ovarian carcinoma with anti-idiotypic antibody].
    Wang J; Qian H; Feng J
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jun; 31(6):353-6. PubMed ID: 9206171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.
    Liu WJ; Liu XJ; Li L; Li Y; Zhang SH; Zhen YS
    Cancer Immunol Immunother; 2014 Dec; 63(12):1261-72. PubMed ID: 25164878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Construction and screening of human anti-idiotypic single chain antibodies of nasopharyngeal carcinoma].
    He XJ; Li GC; Zhu JG; Li YH; Zhou GH
    Ai Zheng; 2004 Feb; 23(2):124-9. PubMed ID: 14960228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.